David S.  Simmons net worth and biography

David Simmons Biography and Net Worth

CEO of PPD
David Simmons joined PPD in 2012 as chairman and chief executive officer. In this role, he leads the company’s global workforce of more than 30,000 employees, in the design and execution of drug development programs on behalf of pharmaceutical industry customers.

Under his leadership, PPD’s total enterprise value has more than tripled, the number of employees has more than doubled and the company has received numerous accolades. Simmons was named the recipient of the Louis V. Gerstner, Jr., Excellence Award by The Carlyle Group in 2017 for exemplifying excellence in leading a Carlyle portfolio company.

Simmons came to PPD following 15 years with Pfizer Inc. In his most recent position with Pfizer, he was president of the emerging markets and established products business units.

Simmons serves on the board of directors for Albany Molecular Research, Inc. and Edelman Financial Engines. He also is active in philanthropic endeavors, which includes serving as a trustee of the Linsly School in Wheeling, West Virginia, and a director for First Tee of Greater Wilmington.

Simmons earned a bachelor’s degree in applied mathematics and industrial management from Carnegie Mellon University.

What is David S. Simmons' net worth?

The estimated net worth of David S. Simmons is at least $31.68 million as of April 14th, 2021. Mr. Simmons owns 669,999 shares of PPD stock worth more than $31,677,553 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Simmons may own. Additionally, Mr. Simmons receives a salary of $3,420,000.00 as CEO at PPD. Learn More about David S. Simmons' net worth.

How old is David S. Simmons?

Mr. Simmons is currently 56 years old. There are 9 older executives and no younger executives at PPD. Learn More on David S. Simmons' age.

What is David S. Simmons' salary?

As the CEO of PPD, Inc., Mr. Simmons earns $3,420,000.00 per year. Learn More on David S. Simmons' salary.

How do I contact David S. Simmons?

The corporate mailing address for Mr. Simmons and other PPD executives is 929 NORTH FRONT STREET, WILMINGTON NC, 28401. PPD can also be reached via phone at 910-251-0081 and via email at [email protected]. Learn More on David S. Simmons' contact information.

Has David S. Simmons been buying or selling shares of PPD?

David S. Simmons has not been actively trading shares of PPD over the course of the past ninety days. Most recently, David S. Simmons sold 100,000 shares of the business's stock in a transaction on Wednesday, April 14th. The shares were sold at an average price of $42.00, for a transaction totalling $4,200,000.00. Following the completion of the sale, the chief executive officer now directly owns 669,999 shares of the company's stock, valued at $28,139,958. Learn More on David S. Simmons' trading history.

Who are PPD's active insiders?

PPD's insider roster includes Glen Donovan (CAO), Ronald Garrow (Insider), Colin Hill (Director), David Johnston (Insider), Karen Kaucic (Insider), and David Simmons (CEO). Learn More on PPD's active insiders.

David S. Simmons Insider Trading History at PPD

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/14/2021Sell100,000$42.00$4,200,000.00669,999View SEC Filing Icon  
3/17/2021Sell22,935$38.00$871,530.00669,999View SEC Filing Icon  
2/12/2021Sell77,065$38.01$2,929,240.65669,999View SEC Filing Icon  
2/10/2020Buy40,000$32.25$1,290,000.00
See Full Table

David S. Simmons Buying and Selling Activity at PPD

This chart shows David S Simmons's buying and selling at PPD by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PPD Company Overview

PPD logo
PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.
Read More

Today's Range

Now: $47.28
Low: $47.28
High: $47.28

50 Day Range

MA: $47.27
Low: $47.10
High: $47.41

2 Week Range

Now: $47.28
Low: $31.54
High: $47.41

Volume

N/A

Average Volume

1,905,567 shs

Market Capitalization

$16.61 billion

P/E Ratio

47.28

Dividend Yield

N/A

Beta

1.96